4 Results for "

DGAT1-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DGAT1-IN-1" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-12425
CAS No.: 1449779-49-0
Purity:  ≥98.0%
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease

DGAT1-IN-1 is a diacylglycerol O-acyltransferase 1 (DGAT1) inhibitor with a human IC50 of <10 nM and a mouse IC50 of <50 nM. DGAT1-IN-1 is applicable to the research of obesity-related diseases, type 2 diabetes and diabetes-related diseases .
loading...
    loading...
Cat. No.: HY-16434
CAS No.: 939375-07-2
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease

DGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1, with IC50s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1. DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndrome .
loading...
    loading...
Cat. No.: HY-15197
CAS No.: 1031336-60-3
Purity:  98.57%
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease

ABT-046 is a potent, selective, and orally active acyl CoA:diacylglycerol acyltransferase 1 (DGAT-1) inhibitor with IC50s of both 8 nM against human and mouse DGAT-1 .
loading...
    loading...
Cat. No.: HY-138942
CAS No.: 1809064-23-0
PF-06427878 is an orally active, selective liver-targeted diacylglycerol acyltransferase 2 (DGAT2) inhibitor with IC50s of 99 nM and 202 nM for human and rat DGAT2, respectively. PF-06427878 shows greater than 470-fold selectivity for DGAT2 over DGAT1, MGAT1, MGAT2 and MGAT3. PF-06427878 can improve liver steatosis and function. PF-06427878 can be used for the study of nonalcoholic fatty liver diseases .
loading...
    loading...